Home
Conditions
Hepatocellular Carcinoma (HCC)

Clinical trial condition

Hepatocellular Carcinoma (HCC)

Explore clinical trials studying Hepatocellular Carcinoma (HCC). Study availability and eligibility vary by location and protocol.

230 public trials 90 recruiting studies

Refine in advanced search Browse all conditions

Hepatocellular Carcinoma (HCC) trial results

Recruiting

mSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis

NCT06778317

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +15 more
Locations: Regional and University Hospital Center of Nancy Vandœuvre-lès-Nancy, France

View Trial Details

Recruiting

Construction and Clinical Validation of a Predictive Model for Postoperative Adjuvant Therapy in Hepatocellular Carcinoma Based on Whole-Slide Digital Pathological Images and Deep Learning

NCT07417800

Conditions: Adenocarcinoma, Adjuvant Chemoradiotherapy, Artificial Intelligent, +14 more
Locations: the Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Lenalidomide Plus Targeted Therapy and Immunotherapy for Refractory HCC

NCT07639138

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Peking Union Medical College Hospital Beijing, No. 1 Shuaifuyuan, Dongcheng District, Beijing, China, China

View Trial Details

Recruiting

Liver Cancer Registry Platform

NCT04510740

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Multiple sites all over germany Multiple Sites, Germany

View Trial Details

Recruiting

Improving the Use of Immunotherapy to Treat Liver Cancer

NCT07623265

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: UZA Antwerp, Belgium

Jessa ziekenhuis Hasselt, Belgium

AZ Groeninge Kortrijk, Belgium

AZ Delta Roeselare, Belgium

View Trial Details

Recruiting

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

NCT07197554

Conditions: Adenocarcinoma, Advanced Solid Tumors, Biliary Tract Cancer (BTC), +30 more
Locations: The City of Hope National Medical Center Duarte, California, United States

Hoag Memorial Hospital Newport Beach, California, United States

Mass General Brigham Cancer Institute Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus

NCT07483359

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: The First Hospital of China Medical University Shenyang, Liaoning, China

View Trial Details

Recruiting

Fostrox Plus Lenvatinib vs Lenvatinib in Advanced Hepatocellular Carcinoma After First-line Immunotherapy

NCT07493668

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: CHA Bundang Medical Center Seongnam-si, Gyeonggi-do, South Korea

View Trial Details

Recruiting

To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors

NCT07594964

Conditions: Adenocarcinoma, Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer), Biliary Tract Diseases, +21 more
Locations: Peking Union Medical College Hospital Beijing, China

Peking University Cancer Hospital Beijing, China

View Trial Details

Recruiting

18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors

NCT07557225

Conditions: Abnormalities, Multiple, Adenocarcinoma, Adnexal Diseases, +81 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

View Trial Details

Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma (HCC) trial results

Related conditions